BioCentury
ARTICLE | Company News

3-Dimensional other research news

October 14, 1996 7:00 AM UTC

3-Dimensional received a $750,000 Phase II SBIR from the NIH to develop ThermoFluor for screening compound libraries for binding to therapeutic targets. The assay, which is based on the thermodynamics...